01 January 2010
By:Jeffrey Liegner
The Endoscopic CycloPhotocoagulation (ECP) technique provides an option for surgical glaucoma management, addressing ciliary aqueous production without the deeply destructive effects of classic ablative procedures. Dr Liegner explains
 |
01 December 2009
A proprietary tonometer has been found to be compatible with the Goldmann tonometer in several clinical trials.
|
01 December 2009
New model produces results comparable with current glaucoma assessment methods
|
01 November 2009
By:William Trattler
Participants in a survey showed low awareness that this option was available for patients with glaucoma.
|
01 November 2009
By:Dr Gail Schwartz
Hyperaemia is one of the main reasons why patients with glaucoma do not comply with or persist with their topical therapeutic regimen.
|
01 October 2009
By:Professor Carl Erb
A review of more than 20,000 glaucoma patients in Germany has discovered that 52.6% have a concomitant diagnosis of dry eye with women more likely to have both diseases than men.
|
01 October 2009
By:Cheryl Guttman, Randolph R. Evans, MD
Dr Randolph Evans argues that endocyclophotocoagulation (ECP) is a simple, safe and effective procedure for achieving IOP lowering in patients with medically controlled glaucoma who also require cataract surgery
|
01 September 2009
By:Nancy Groves, Wallace L.M Alward, MD
Application of genetic knowledge holds huge potential for the future and some believe that it has potential to become larger than the pharmaceutical market. Here Dr Alward examines what it has offered for the understanding and future treatment of glaucoma. Until recently, breakthroughs in glaucoma genetics emerged from painstaking family research, with the discovery of LOXL1 being the exception.
|
| 
